Say Goodbye to Back Pain with These Proven Techniques

Say Goodbye to Back Pain with These Proven Techniques

Wearable Smart Devices for Real-Time Position Correction


The Role of Wearable Smart Devices in Changing Neck And Back Pain Therapies


As we enter the advanced landscape of medical care in 2025, pain in the back continues to be a relentless condition impacting millions worldwide. New Research: Top 3 Breakthroughs in Back Pain Relief . However, the introduction of wearable clever devices for real-time pose adjustment stands apart as a beacon of development, guaranteeing a revolutionary technique to minimizing this old-time trouble. This essay looks into the transformative potential of such gadgets in the world of back pain therapies.


Gone are the days when pain in the back sufferers depend only on routine check outs to a physio therapist or chiropractic physician. With the introduction of wearable smart gadgets customized for position correction, individuals are now empowered to organize their back health in actual time. These cutting-edge gadgets are ingeniously designed to be light-weight, unobtrusive, and perfectly integrated into the daily lives of customers.


At the heart of these devices lies the innovative blend of sensing units and artificial intelligence. Sensing units continually keep an eye on the users position throughout the day, spotting slouches, imbalances, and any type of inconsistencies from a healthy and balanced back curvature. When bad position is identified, the tool sends out gentle vibrations or acoustic cues, motivating the customer to readjust their setting. This instantaneous feedback loophole not just assists in remedying posture in the moment but additionally trains the muscle mass and mind to preserve an ideal stance gradually, properly minimizing stress and anxiety on the back.


Furthermore, the real-time data accumulated by these tools provides important insights right into postural behaviors, helping customers to determine patterns and activities that add to their back pain. By syncing with mobile phones or various other clever technologies, the tool can supply individualized guidance, workouts, and also leisure strategies, all customized to the users particular demands and development.


The implications of this innovation are profound for preventative care. By resolving poor position before it becomes a chronic problem, these wearable devices have the possible to substantially reduce the occurrence of pain in the back, which subsequently could reduce the need for even more invasive treatments like surgery or long-lasting medicine.


Moreover, the integration of such tools right into telehealth services boosts the range of remote medical diagnosis and treatment. Individuals can share their stance data with doctor, enabling more exact evaluations and customized treatment plans without the need for regular in-person gos to.


To conclude, as we seek to 2025 and past, wearable smart gadgets for real-time posture improvement attract attention as an innovative treatment for neck and back pain. By merging the benefit of wearable technology with the accuracy of real-time information, these devices offer a proactive technique to spinal

Genetics Therapy for Long-Term Pain Alleviation


Gene Treatment for Long-Term Pain Alleviation: A Peek right into the Future of Neck And Back Pain Management


The year is 2025, and the landscape of back pain treatment is seeing a transformative age, identified by technology and advanced technology. Among one of the most advanced treatments that have actually arised, genetics therapy sticks out as a sign of hope for those that deal with persistent neck and back pain. This unique method is not just introducing in its approach but likewise promises long-lasting relief, which has been a distant dream for several people.


Genetics therapy for back pain operates on a principle that is as sophisticated as it is intricate-- it includes the alteration of a people genes to treat or avoid condition. In the context of neck and back pain, this treatment targets the hereditary elements that add to the swelling, nerve damage, and cells deterioration that are frequently at the origin of persistent pain.


The process of gene therapy begins with the recognition of details genetics that influence pain feeling or inflammatory reactions. Researchers have made significant strides in this area, determining hereditary markers that can be controlled to decrease pain without the requirement for repeated medicine programs. As soon as these genes are determined, a safe infection or one more vector is genetically crafted to lug healthy and balanced or tweaked genetics right into the human cells.


Clients going through genetics therapy for back pain obtain a shot straight into the affected location of the back. This localized method ensures that the restorative genetics get to the desired site, supplying a targeted treatment that lessens systemic negative effects. The presented genes then function to either reduce the overactive pain signals or advertise the recovery of broken cells.


What sets gene treatment besides conventional pain management techniques is its capacity for lasting relief. Rather than covering up signs with painkillers or going through intrusive surgical treatments, individuals can eagerly anticipate a future where their bodys own hereditary make-up is harnessed to battle pain from within. As the changed genes integrate right into the patients DNA, the therapeutic impacts can maintain for years, significantly improving the quality of life for those afflicted with chronic pain in the back.


Additionally, gene therapy is customized. Each treatment can be customized to the individuals hereditary account, enhancing the performance and reducing the chance of damaging reactions. This bespoke technique to pain monitoring declares a brand-new era of accuracy medicine, where therapies are designed to fit each clients special hereditary plan.


The promise of genetics treatment for lasting pain relief is not without its difficulties. The road to prevalent medical application has actually been led with strenuous screening, honest factors to consider, and governing authorizations. Nonetheless, the strides made

Virtual Truth as a Device for Chronic Pain In The Back Monitoring


Online Reality as a Tool for Chronic Neck And Back Pain Management: A Peek right into the Future of Healing


As we venture much deeper right into the 21st century, the world of pain management is going through a change, one that merges the borders between modern technology and human feeling. Online Truth (VR), when a fantasy of sci-fi, has now come to be a sign of hope for those experiencing chronic back pain. In the advanced landscape of 2025, VR isn't merely a device for entertainment yet an innovative restorative method that is redefining the way we come close to back pain treatment.


The principle of using virtual reality for chronic neck and back pain monitoring comes from its capability to submerse patients in an alternating reality, one where the constraints and pains of their physical bodies can be gone beyond. This immersive experience is more than just an interruption; it's a kind of cognitive behavior modification that instructs people just how to much better understand and handle their pain.


In a regular virtual reality neck and back pain administration session, individuals wear a virtual reality headset and are transferred to calm atmospheres, be it a sunlit woodland glade or a peaceful beach. These setups are not random; they are carefully crafted to advertise leisure and mindfulness. The person participates in assisted workouts and activities made to promote movement, versatility, and stamina, all within the comfort of a digital world that decreases the concern of pain that frequently accompanies physical treatment.


The scientific research behind this innovative method depends on the brains ability to be tricked by virtual stimuli. As individuals browse their online surroundings, their brains are coaxed right into producing pain-inhibiting feedbacks. This phenomenon, called "" virtual reality analgesia,"" has revealed appealing cause minimizing the understanding of pain. Additionally, VRs interactive nature encourages active involvement, which is important in the recovery process.


The psychological benefits of virtual reality treatment are just as remarkable. Persistent pain in the back can frequently result in anxiety, anxiety, and a sense of seclusion. With virtual reality, individuals connect with an area of fellow sufferers and doctor, promoting a sense of support and camaraderie that is important for psychological health. They learn dealing strategies and mindfulness techniques that not only aid handle pain however also boost their total quality of life.


As we accept these introducing treatments in 2025, we see a shift from a dependence on drugs to a much more holistic technique to pain monitoring. VR treatment is not a standalone remedy yet a corresponding treatment that improves standard therapies such as physical treatment, medication, and interventional treatments. It represents a tailored approach,

Custom-made 3D-Printed Back Implants and Sustains


In the evolving landscape of clinical modern technology, the realm of orthopedic care has been especially changed by the development of tailored 3D-printed spine implants and supports. As we look in the direction of 2025, this innovative method stands as a beacon of expect those dealing with chronic pain in the back, heralding a brand-new era of personalized and effective treatment alternatives.


Personalized 3D-printed spine implants and supports are an item of the marital relationship in between innovative imaging techniques and sophisticated 3D printing technology. By making use of detailed scans of an individuals one-of-a-kind spinal anatomy, physician can now create implants and sustains that are customized to the people details needs. This degree of customization makes certain that the implants fit perfectly, lessening the threat of being rejected and difficulties that can arise from ill-fitting, mass-produced options.


The effects for pain in the back sufferers are extensive. For many, standard back surgical treatment can be an overwhelming prospect, with long recovery times and the potential for only partial relief from pain. Nonetheless, with the accuracy used by 3D printing, specialists can target the damaged location with a much greater level of accuracy, leading to more successful results. This can lead to significantly reduced pain, boosted movement, and a quicker go back to daily activities.


In addition, the products utilized in 3D printing can be chosen for their compatibility with the human body and their toughness. This means that the implants can be developed not just to offer architectural support yet additionally to assist in the bodys natural healing procedures. Some 3D-printed products can also promote bone growth, leading to a more powerful, more incorporated repair work with time.


For those with degenerative problems or complicated spine issues, personalized 3D-printed implants stand for a quantum leap onward. Patients who may have encountered a life time of pain and minimal movement currently have the possible to enjoy an extra active and comfy life. The degree of personalization in the implants can address the root cause of pain with unmatched accuracy, reducing the demand for pain medicines and additional interventions.


In 2025, as this innovation ends up being extra widespread and easily accessible, we can expect a considerable shift in exactly how back pain is treated. Customized 3D-printed spine implants and supports will likely end up being the criterion of care, supplying hope and healing to the numerous people afflicted by pain in the back. This is really a cutting edge advancement; one that assures to redefine the boundaries of spine treatment and recover the lifestyle to countless people around the world.

Chronic pain
Other names Chronic pain syndrome
Specialty Specialist in pain, neurology and psychology[1]
Symptoms Pain lasts longer than the expected period of recovery.
Usual onset All age groups
Duration At least 3 months
Causes High blood sugar, cancer, genetic disorder in neural differentiation, tissue damage, neurological disorders, viral diseases[2]
Risk factors Diabetes, cancer, heart disease[citation needed]
Diagnostic method Based on medical history, clinical examination, questionnaire and neuroimaging[2]
Differential diagnosis Gastric ulcer, bone fracture, hernia, neoplasia of the spinal cord[3]
Medication Non-opioid: ibuprofen, acetaminophen, naproxen, NSAIDs, olanzapine[citation needed]
Opioid: morphine, codeine, buprenorphine[4]
Frequency 8% to 55.2% in different countries[citation needed]

Chronic pain is pain that persists or recurs for longer than 3 months.[7][8][9] It is also known as gradual burning pain, electrical pain, throbbing pain, and nauseating pain. This type of pain is in contrast to acute pain, which is pain associated with a cause that can be relieved by treating the cause, and decreases or stops when the cause improves.[10] Chronic pain can last for years.[11] Persistent pain often serves no apparent useful purpose.[12]

The most common types of chronic pain are back pain, severe headache, migraine, and facial pain.

Chronic pain can cause very severe psychological and physical effects that sometimes continue until the end of life. Analysis of the grey matter (damage to brain neurons), insomnia and sleep deprivation, metabolic problems, chronic stress, obesity, and heart attack are examples of physical disorders; and depression, and neurocognitive disorders are examples of mental disorders.

A wide range of treatments are performed for this disease; drug therapy including opioid and non-opioid drugs, cognitive behavioral therapy and physical therapy are the most significant of them. Medications such as aspirin and ibuprofen are used for milder pain and morphine and codeine for severe pain. Other treatment methods, such as behavioral therapy and physiotherapy, are often used as a supplement along with drugs due to their low effectiveness. There is currently no definitive cure for chronic pain, and research continues into a wide variety of new management and therapeutic interventions, such as nerve block and radiation therapy.

An average of 8% to 11.2% of people in different countries have severe chronic pain, with higher incidence in industrialized countries. Epidemiological studies show prevalence in countries varying from 8% to 55.2% (for example 30-40% in the US and 10-20% in Iran and Canada). Chronic pain is a disease that affects more people than diabetes, cancer, and heart disease.

According to the estimates of the American Medical Association, the costs related to chronic pain in the US are about US$560-635b.

Classification

[edit]

In medical classification systems

[edit]

ICD-11

[edit]

In ICD-11 chronic pain is classified under MG30. It is described as pain that persists or recurs for longer than 3 months. Contributing factors can be multiple, and can include biological, psychological and social factors.[7]

Subcategories of MG30 are;

    • primary (MG 30.0)
    • cancer related
    • postsurgical or post traumatic
    • secondary musculoskeletal
    • secondary visceral
    • neuropathic
    • secondary headache or orofacial
    • Other specified
    • Unspecified[7]


Primary chronic pain (MG30.0) has subcategories;

    • widespread (diffuse pain in at least 4 of 5 body regions, and is associated with emotional distress or functional disability. This subcategory is an inclusion for fibromyalgia.[13])
    • primary musculoskeletal
    • primary headache or orofacial
    • Complex regional pain syndrome
    • Painful bruising syndrome
    • Other specified
    • Unspecified[7]

Specific pain syndromes can be placed in these categories.

DSM-5

[edit]

According to the DSM-5 index, a complication is chronic when the resulting complication (pain, disorder, and illness) lasts for a period of more than six months (this type of classification does not have any prerequisites such as physical or mental injury).[14]

IASP

[edit]

The International Association for the Study of Pain (IASP) describes pain as chronic if it persists for months or even years, beyond the usual recovery time from an injury or illness.[15] The IASP uses the terms nociceptive, neuropathic and nociplastic (see below).[16]

Other classification approaches

[edit]

Nociceptive/Neuropathic/Nociplastic

[edit]

In many cases pain fits into 3 categories;[17]

  • "nociceptive"; pain caused by inflamed or damaged tissue that activates special pain sensors called nociceptors.[18] Nociceptive pain can be divided into "superficial," "deep physical" and "deep visceral" pain.[19]
  • "nociplastic"; pain that arises despite no clear evidence of tissue or somatosensory system damage causing the pain.[24]

By originating body area

[edit]

Chronic pain can be classified by origin area as neuropathic, musculoskeletal, visceral, inflammatory or central sensitisation.[11]

Primary or secondary

[edit]

Chronic pain syndromes can be divided between primary and secondary. Secondary pain results from another disease.

Etiology

[edit]

Chronic pain has many pathophysiological and environmental causes and can occur in cases such as neuropathy of the central nervous system, after cerebral hemorrhage, tissue damage such as extensive burns, inflammation, autoimmune disorders such as rheumatoid arthritis, psychological stress such as headache, migraine or abdominal pain (caused by emotional, psychological or behavioral) and mechanical pain caused by tissue wear and tear such as arthritis.[2] In some cases, chronic pain can be caused by genetic factors which interfere with neuronal differentiation, leading to a permanently lowered threshold for pain.[25]

The pathophysiological etiology of chronic pain remains unclear. Many theories of chronic pain[26][27] fail to clearly explain why the same pathological conditions do not invariably result in chronic pain. Patients' anatomical predisposition to proximal neural compression (in particular of peripheral nerves) may be the answer to this conundrum. Proximal neural lesion at the level of the dorsal root ganglion (DRG) may drive a vicious cycle of chronic pain by causing postural protection of the painful site and consequent neural compression in the same spinal region. Difficulties in diagnosing proximal neural lesion[28] may account for the theoretical perplexity of chronic pain.

Pathophysiology

[edit]
Continuous pressure on the spine can destroy the intervertebral disc and cause the sciatic nerve to actively produce pain.

The mechanism of continuous activation and transmission of pain messages, leads the body to an activity to relieve pain (a mechanism to prevent damage in the body), this action causes the release of prostaglandin and increase the sensitivity of that part to stimulation; Prostaglandin secretion causes unbearable and chronic pain.[29] Under persistent activation, the transmission of pain signals to the dorsal horn may produce a pain wind-up phenomenon. This triggers changes that lower the threshold for pain signals to be transmitted. In addition, it may cause non-nociceptive nerve fibers to respond to, generate, and transmit pain signals.[30][31] Researchers believe that the nerve fibers that cause this type of pain are group C nerve fibers; these fibers are not myelinated (have low transmission speed) and cause long-term pain.[31][32]

These changes in neural structure can be explained by neuroplasticity.[32] When there is chronic pain, the somatotopic arrangement of the body (the distribution view of nerve cells) is abnormally changed due to continuous stimulation and can cause allodynia or hyperalgesia.[a] In chronic pain, this process is difficult to reverse or stop once established.[34] EEG of people with chronic pain showed that brain activity and synaptic plasticity change as a result of pain, and specifically, the relative activity of beta wave increases and alpha and theta waves decrease.[33]

Inefficient management of dopamine secretion in the brain can act as a common mechanism between chronic pain, insomnia and major depressive disorder and cause its unpleasant side effects.[35] Astrocytes, microglia and satellite glial cells also lose their effective function in chronic pain. Increasing the activity of microglia, changing microglia networks, and increasing the production of chemokines and cytokines by microglia may exacerbate chronic pain.[29][36] It has also been observed that astrocytes lose their ability to regulate the excitability of neurons and increase the spontaneous activity of neurons in pain circuits.[36]

Disease associations

[edit]

Some diseases such as diabetes, shingles, phantom limb pain, hypertension, and stroke play a role in the formation of chronic pain.

Chronic pain is associated with fibromyalgia.

Prognosis and outcomes

[edit]

Complete, longterm remission of many types of chronic pain is rare.[37] Chronic pain is often difficult to treat.[38]

Chronic pain can significantly reduce individuals' quality of life, productivity, and wages, worsen existing health issues, and provoke the onset of new conditions like major depression, anxiety disorders, and substance use disorders.[2]

Many of the often-used medications for chronic pain carry risks for side effects and complications. For example, chronic use of opioids is associated with decreased life expectancy and increased mortality of patients relative to non-users.[39][40] Acetaminophen, a frequently used drug in chronic pain management, can cause hepatotoxicity when taken in excess of four grams per day,[41][42] and even therapeutic doses administered to pain patients with chronic liver disease may cause hepatotoxicity. [43] Long-term risks and side effects of opioids, another class of analgesic, include constipation, drug tolerance and dependence, nausea, indigestion, arrhythmia (e.g., QT prolongation during methadone treatment), endocrine gland disruptions promoting amenorrhea, erectile dysfunction, and gynecomastia, and fatigue. A major public health and clinical concern in and since the 2010s has been opioid overdose, especially in the context of an opioid epidemic in the United States.[2][44]

As of 2011, drug treatments for chronic non-cancer pain reduced pain by 30%, although effectiveness varied widely by modality, diagnosis, and population studied.[45] This reduction in pain can significantly improve patients' performance and quality of life. However, the general and long-term prognosis of chronic pain shows decreased function and quality of life.[46] Also, this disease causes many complications and increases the possibility of death of patients and suffering from other chronic diseases and obesity.[2] Similarly, patients with chronic pain who require opioids often develop drug tolerance over time, and this increase in the amount of the dose taken to be effective increases the risk of side effects and death.[2]

Mental disorders can amplify pain signals and make symptoms more severe.[47] In addition, comorbid psychiatric disorders, such as major depressive disorder, can significantly delay the diagnosis of pain disorders.[48] Major depressive disorder and generalized anxiety disorder are the most common comorbidities associated with chronic pain. Patients with underlying pain and comorbid mental disorders receive twice as much medication from doctors annually as compared to patients who do not have such co-morbidities.[49] Studies have shown that when coexisting diseases exist along with chronic pain, the treatment and improvement of one of these disorders can be effective in the improvement of the other.[50][51]

Patients with chronic pain are at higher risk for suicide and suicidal thoughts. Research has shown approximately 20% of people with suicidal thoughts, and between 5 and 14% of patients with chronic pain commit suicide.[50] Of patients who attempted suicide, 53.6% died of gunshot wounds, and 16.2% died of opioid overdose.[51]

Sleep disturbance, and insomnia due to medication and illness symptoms are often experienced by those with chronic pain.[52] These conditions can be difficult to treat due to the high potential of medication interactions, especially when the conditions are treated by different doctors.[53]

Severe chronic pain is associated with increased risk of death over a ten-year period, particularly from heart disease and respiratory disease.[54] Several mechanisms have been proposed for this increase, such as an abnormal stress response in the body's endocrine system.[55] Additionally, chronic stress seems to affect risks to heart and lung (cardiovascular) health by increasing how quickly plaque can build up on artery walls (arteriosclerosis). However, further research is needed to clarify the relationship between severe chronic pain, stress and cardiovascular health.[54]

People with chronic pain tend to have higher rates of depression[56] and although the exact connection between the comorbidities is unclear, a 2017 study on neuroplasticity found that "injury sensory pathways of body pains have been shown to share the same brain regions involved in mood management."[57] Chronic pain can contribute to decreased physical activity due to fear of making the pain worse. Pain intensity, pain control, and resilience to pain can be influenced by different levels and types of social support that a person with chronic pain receives, and are also influenced by the person's socioeconomic status.[58]

In a study, Mendelian randomization was used to identify causal relationships between chronic pain and certain psychiatric, cardiovascular, and inflammatory conditions that were initially thought to be unrelated to pain. It was found that exposure to depression increases the likelihood of reporting pain, but not the other way around. Exposure to coronary diseases increases the risk of developing chronic pain, and vice versa. An increase in body mass index modestly raises the likelihood of experiencing pain, while high blood HDL levels reduce the probability of suffering from chronic pain. Regarding inflammatory traits, exposure to asthma increases the likelihood of experiencing pain, and vice versa.[59]

Chronic pain of different causes has been characterized as a disease that affects brain structure and function. MRI studies have shown abnormal anatomical[60] and functional connectivity, even during rest[61][62] involving areas related to the processing of pain. Also, persistent pain has been shown to cause grey matter loss, which is reversible once the pain has resolved.[63][64]

One approach to predicting a person's experience of chronic pain is the biopsychosocial model, according to which an individual's experience of chronic pain may be affected by a complex mixture of their biology, psychology, and their social environment.[65]

Chronic pain may be an important contributor to suicide.[66]

Management

[edit]

Overview

[edit]

Pain management is a branch of medicine that uses an interdisciplinary approach. The combined knowledge of various medical professions and allied health professions is used to ease pain and improve the quality of life of those living with pain.[67] The typical pain management team includes medical practitioners (particularly anesthesiologists), rehabilitation psychologists, physiotherapists, occupational therapists, physician assistants, and nurse practitioners.[68] Acute pain usually resolves with the efforts of one practitioner; however, the management of chronic pain frequently requires the coordinated efforts of a treatment team.[69][70][71]

A multimodal treatment approach is essential for better pain control and outcomes, as well as minimizing the need for high-risk treatments such as opioid medications. Managing comorbid depression and anxiety is critical in reducing chronic pain.[2][50] Patients with chronic pain should be carefully monitored for severe depression and any suicidal thoughts and plans.[2][51] Periodic referral of the patient to the doctor for physical examination and to check the effectiveness of treatment too is necessary, and the rapid and correct treatment and management of chronic pain can prevent the occurrence of potential negative consequences on the patient's life and increase in healthcare costs.[2]

As of 2024, the patient is encouraged to play a major role in the management of their pain.[72]

Medications

[edit]

Various non-opioid medicines are initially recommended to treat chronic pain, depending on whether the pain is due to tissue damage or is neuropathic.[73][74]

Some people with chronic pain may benefit from opioid treatment while others can be harmed by it.[75][76]

People with non-cancer pain who have not been helped by non-opioid medicines might be recommended to try opioids if there is no history of substance use disorder and no current mental illness.[77]

A 2023 review said that future chronic pain diagnosis and treatment would be more personalized and precision based.[78]

Nonopioids

[edit]

Initially recommended efforts are non-opioid based therapies.[77] Non-opioid treatment of chronic pain with pharmaceutical medicines might include acetaminophen (paracetamol)[79] or NSAIDs.[80]

Various other nonopioid medicines can be used, depending on whether the pain is a result of tissue damage or is neuropathic (pain caused by a damaged or dysfunctional nervous system).

There is limited evidence that cancer pain or chronic pain from tissue damage as a result of a conditions (e.g. rheumatoid arthritis) is best treated with opioids.

For neuropathic pain other drugs may be more effective than opioids,[73][74][81][82] such as tricyclic antidepressants,[83] serotonin-norepinephrine reuptake inhibitors,[84] and anticonvulsants.[84]

Some atypical antipsychotics, such as olanzapine, may also be effective, but the evidence to support this is in very early stages.[85] In women with chronic pain, hormonal medications such as oral contraceptive pills ("the pill") might be helpful.[86] When there is no evidence of a single best fit, doctors may need to look for a treatment that works for the individual person.[83]

Nefopam may be used when common alternatives are contraindicated or ineffective, or as an add-on therapy. However it is associated with adverse drug reactions and is toxic in overdose.[87]

Opioids

[edit]

In those who have not benefited from other measures and have no history of either mental illness or substance use disorder treatment with opioids may be tried.[77] If significant benefit does not occur it is recommended that they be stopped.[77] In those on opioids, stopping or decreasing their use may improve outcomes including pain.[88]

Some people with chronic pain benefit from opioid treatment and others do not; some are harmed by the treatment.[75] Possible harms include reduced sex hormone production, hypogonadism, infertility, impaired immune system, falls and fractures in older adults, neonatal abstinence syndrome, heart problems, sleep-disordered breathing, physical dependence, addiction, abuse, and overdose.[89][90]

It is difficult for doctors to predict who will use opioids just for pain management and who will go on to develop an addiction. It is also challenging for doctors to know which patients ask for opioids because they are living with an opioid addiction. Withholding, interrupting or withdrawing opioid treatment in people who benefit from it can cause harm.[75]

Psychological treatments

[edit]

Psychological treatments, including cognitive behavioral therapy[91][92] and acceptance and commitment therapy[93][94] can be helpful for improving quality of life and reducing pain interference. Brief mindfulness-based treatment approaches have been used, but they are not yet recommended as a first-line treatment.[95] The effectiveness of mindfulness-based pain management (MBPM) has been supported by a range of studies.[4][96][97]

Among older adults psychological interventions can help reduce pain and improve self-efficacy for pain management.[98] Psychological treatments have also been shown to be effective in children and teens with chronic headache or mixed chronic pain conditions.[99]

Exercise

[edit]

While exercise has been offered as a method to lessen chronic pain and there is some evidence of benefit, this evidence is tentative.[100] For people living with chronic pain, exercise results in few side effects.[100]

Other interventions

[edit]

Interventional pain management may be appropriate, including techniques such as trigger point injections, neurolytic blocks, and radiotherapy. While there is no high quality evidence to support ultrasound, it has been found to have a small effect on improving function in non-specific chronic low back pain.[101]

Alternative medicine

[edit]

Alternative medicine refers to health practices or products that are used to treat pain or illness that are not necessarily considered a part of conventional medicine.[102] When dealing with chronic pain, these practices generally fall into the following four categories: biological, mind-body, manipulative body, and energy medicine.[102]

Implementing dietary changes, which is considered a biological-based alternative medicine practice, has been shown to help improve symptoms of chronic pain over time.[102] Adding supplements to one's diet is a common dietary change when trying to relieve chronic pain, with some of the most studied supplements being: acetyl-L-carnitine, alpha-lipoic acid, and vitamin E.[102][103][104][105] Vitamin E is perhaps the most studied out of the three, with strong evidence that it helps lower neurotoxicity in those with cancer, multiple sclerosis, and cardiovascular diseases.[105]

Hypnosis, including self-hypnosis, has tentative evidence.[106] Hypnosis, specifically, can offer pain relief for most people and may be a safe alternative to pharmaceutical medication.[107] Evidence does not support hypnosis for chronic pain due to a spinal cord injury.[108]

Preliminary studies have found medical marijuana to be beneficial in treating neuropathic pain, but not other kinds of long term pain.[109] As of 2018, the evidence for its efficacy in treating neuropathic pain or pain associated with rheumatic diseases is not strong for any benefit and further research is needed.[110][111][112] For chronic non-cancer pain, a recent study concluded that it is unlikely that cannabinoids are highly effective.[113] However, more rigorous research into cannabis or cannabis-based medicines is needed.[112]

Tai chi has been shown to improve pain, stiffness, and quality of life in chronic conditions such as osteoarthritis, low back pain, and osteoporosis.[114][115] Acupuncture has also been found to be an effective and safe treatment in reducing pain and improving quality of life in chronic pain including chronic pelvic pain syndrome.[116][117]

Transcranial magnetic stimulation for reduction of chronic pain is not supported by high quality evidence, and the demonstrated effects are small and short-term.[118]

Spa therapy could potentially improve pain in patients with chronic lower back pain, but more studies are needed to provide stronger evidence of this.[119]

While some studies have investigated the efficacy of St John's Wort or nutmeg for treating neuropathic (nerve) pain, their findings have raised serious concerns about the accuracy of their results.[120]

Kinesio tape has not been shown to be effective in managing chronic non-specific low-back pain.[121]

Myofascial release has been used in some cases of fibromyalgia, chronic low back pain, and tennis elbow but there is not enough evidence to support this as method of treatment.[122]

Epidemiology

[edit]

Chronic pain is common.

  • Epidemiological studies have found that 8–11.2% of people in various countries have chronic widespread pain.[38] Chronic pain varies in different countries affecting anywhere from 8% to 55% of the population. It affects women at a higher rate than men, and chronic pain uses a large amount of healthcare resources around the globe.[123][38]
  • A large-scale telephone survey of 15 European countries and Israel found that 19% of respondents over 18 years of age had suffered pain for more than 6 months, including the last month, and more than twice in the last week, with pain intensity of 5 or more for the last episode, on a scale of 1 (no pain) to 10 (worst imaginable). 4839 of these respondents with chronic pain were interviewed in-depth. Sixty-six percent scored their pain intensity at moderate (5–7), and 34% at severe (8–10); 46% had constant pain, 56% intermittent; 49% had suffered pain for 2–15 years; and 21% had been diagnosed with depression due to the pain. Sixty-one percent were unable or less able to work outside the home, 19% had lost a job, and 13% had changed jobs due to their pain. Forty percent had inadequate pain management and less than 2% were seeing a pain management specialist.[124]
  • In the United States, chronic pain has been estimated to occur in approximately 35% of the population, with approximately 50 million Americans experiencing partial or total disability as a consequence.[125] According to the Institute of Medicine, there are about 116 million Americans living with chronic pain, which suggests that approximately half of American adults have some chronic pain condition.[126][127] The Mayday Fund estimate of 70 million Americans with chronic pain is slightly more conservative.[128] In an internet study, the prevalence of chronic pain in the United States was calculated to be 30.7% of the population: 34.3% for women and 26.7% for men.[129] A 2021 survey found chronic pain sufferers were 55% female.[130]
  • In Canada it is estimated that approximately 1 in 5 Canadians live with chronic pain and half of those people have lived with chronic pain for 10 years or longer.[131] Chronic pain in Canada also occurs more and is more severe in women and Canada's Indigenous communities.[131]
  • In the UK chronic pain affects 13–50% of adults.[132][9]10.4–14.3% of people with chronic pain have moderate-to-severe disabling chronic pain.[132]

Psychological aspects

[edit]

Personality

[edit]

Two of the most frequent personality profiles found in people with chronic pain by the Minnesota Multiphasic Personality Inventory (MMPI) are the conversion V and the neurotic triad. The conversion V personality expresses exaggerated concern over body feelings, develops bodily symptoms in response to stress, and often fails to recognize their own emotional state, including depression. The neurotic triad personality also expresses exaggerated concern over body feelings and develops bodily symptoms in response to stress, but is demanding and complaining.[133]

Some investigators have argued that it is this neuroticism that causes acute pain to turn chronic, but clinical evidence points the other way, to chronic pain causing neuroticism. When long term pain is relieved by therapeutic intervention, scores on the neurotic triad and anxiety fall, often to normal levels.[134][135][136][137] Self-esteem, often low in people with chronic pain, also shows improvement once pain has resolved.[137]

It has been suggested that catastrophizing might play a role in the experience of pain. Pain catastrophizing is the tendency to describe a pain experience in more exaggerated terms than the average person, to think a great deal more about the pain when it occurs, or to feel more helpless about the experience.[138] People who score highly on measures of catastrophization are likely to rate a pain experience as more intense than those who score low on such measures. It is often reasoned that the tendency to catastrophize causes the person to experience the pain as more intense. One suggestion is that catastrophizing influences pain perception through altering attention and anticipation, and heightening emotional responses to pain.[139] However, at least some aspects of catastrophization may be the product of an intense pain experience, rather than its cause. That is, the more intense the pain feels to the person, the more likely they are to have thoughts about it that fit the definition of catastrophization.[140]

Comorbidity with trauma

[edit]

Individuals with post-traumatic stress disorder (PTSD) have a high comorbidity with chronic pain.[141] Patients with both PTSD and chronic pain report higher severity of pain than those who do not have a PTSD comorbidity.[142][143]

Comorbidity with depression

[edit]

People with chronic pain may also have symptoms of depression.[144][145] In 2017, the British Medical Association found that 49% of people with chronic pain had depression.[146]

Effect on cognition

[edit]

Chronic pain's impact on cognition is an under-researched area, but several tentative conclusions have been published. Most people with chronic pain complain of cognitive impairment, such as forgetfulness, difficulty with attention, and difficulty completing tasks. Objective testing has found that people in chronic pain tend to experience impairment in attention, memory, mental flexibility, verbal ability, speed of response in a cognitive task, and speed in executing structured tasks.[147] A review of studies in 2018 reports a relationship between people in chronic pain and abnormal results in test of memory, attention, and processing speed.[148]

Social and personal impacts

[edit]

Social support

[edit]

Social support has important consequences for individuals with chronic pain. In particular, pain intensity, pain control, and resiliency to pain have been implicated as outcomes influenced by different levels and types of social support. Much of this research has focused on emotional, instrumental, tangible and informational social support. People with persistent pain conditions tend to rely on their social support as a coping mechanism and therefore have better outcomes when they are a part of larger more supportive social networks. Across a majority of studies investigated, there was a direct significant association between social activities or social support and pain. Higher levels of pain were associated with a decrease in social activities, lower levels of social support, and reduced social functioning.[149][150]

Racial disparities

[edit]

Evidence exists for unconscious biases and negative stereotyping against racial minorities requesting pain treatment, although clinical decision making was not affected, according to one 2017 review.[151] Minorities may be denied diagnoses for pain and pain medications, and are more likely to go through substance abuse assessment, and are less likely to transfer for pain specialist referral.[152] A 2010 University of Michigan Health study found that black patients in pain clinics received 50% of the amount of drugs that patients who were white received.[153] Preliminary research showed that health providers might have less empathy for black patients and underestimated their pain levels, resulting in treatment delays.[151][152] Minorities may experience a language barrier, limiting the high level of engagement between the person with pain and health providers for treatment.[152]

Perceptions of injustice

[edit]

Similar to the damaging effects seen with catastrophizing, perceived injustice is thought to contribute to the severity and duration of chronic pain.[154] Pain-related injustice perception has been conceptualized as a cognitive appraisal reflecting the severity and irreparability of pain- or injury-related loss (e.g., "I just want my life back"), and externalizing blame and unfairness ("I am suffering because of someone else's negligence.").[155] It has been suggested that understanding problems with top down processing/cognitive appraisals can be used to better understand and treat this problem.[156]

Chronic pain and COVID-19

[edit]

COVID-19 disrupted the lives of many, leading to major physical, psychological and socioeconomic impacts in the general population.[157] Social distancing practices defining the response to the pandemic altered familiar patterns of social interaction, creating the conditions for what some psychologists described as a period of collective grief.[158]

With a large proportion of the global population enduring prolonged periods of social isolation and distress, one study found that people with chronic pain from COVID-19 experienced more empathy towards their suffering during the pandemic.[157]

Relationship with conventional medicine

[edit]

Individuals with chronic pain tend to embody an ambiguous status, at times expressing that their type of suffering places them between and outside of conventional medicine.[159]

Effect of chronic pain in the workplace

[edit]

In the workplace, chronic pain conditions are a significant problem for both the person with the condition and the organization; a problem only expected to increase in many countries due to an aging workforce.[65] In light of this, it may be helpful for organizations to consider the social environment of their workplace, and how it may be working to ease or worsen chronic pain issues for employees.[65] As an example of how the social environment can affect chronic pain, some research has found that high levels of socially prescribed perfectionism (perfectionism induced by external pressure from others, such as a supervisor) can interact with the guilt felt by a person with chronic pain, thereby increasing job tension, and decreasing job satisfaction.[65]

See also

[edit]

Notes

[edit]
  1. ^ The continuous sending of messages from one body part causes its somatotopic area to become larger than the normal state, and the brain of the area attaches more and abnormal energy and importance to the tissue stimuli of that part of the body.[33]

References

[edit]
  1. ^ Turk DC, Okifuji A (2001). "Pain terms and taxonomies". In Loeser D, Butler SH, Chapman JJ, Turk DC (eds.). Bonica's Management of Pain (3rd ed.). Lippincott Williams & Wilkins. pp. 18–25. ISBN 978-0683304626.
  2. ^ a b c d e f g h i j Dydyk, Alexander M; Till, Conermann (June 2023). Abrazo Central Campus (ed.). "Chronic Pain". StatPearls [Internet]. StatPearls Publishing. PMID 31971706. Archived from the original on 2024-03-06. Retrieved 2024-01-24.
  3. ^ "Chronic Pain Syndrome Differential Diagnoses". emedicine.medscape.com. 2020-01-14. Archived from the original on 2023-12-10. Retrieved 2024-01-24.
  4. ^ a b Mehan S, Morris J (2018). "A literature review of Breathworks and mindfulness intervention". British Journal of Healthcare Management. 24 (5): 235–241. doi:10.12968/bjhc.2018.24.5.235. ISSN 1358-0574.
  5. ^ Buckwalter, Joseph A. (October 2003). "Sports, joint injury, and posttraumatic osteoarthritis". The Journal of Orthopaedic and Sports Physical Therapy. 33 (10): 578–588. doi:10.2519/jospt.2003.33.10.578. ISSN 0190-6011. PMID 14620787.
  6. ^ Saxon, L.; Finch, C.; Bass, S. (August 1999). "Sports participation, sports injuries and osteoarthritis: implications for prevention". Sports Medicine. 28 (2): 123–135. doi:10.2165/00007256-199928020-00005. ISSN 0112-1642. PMID 10492030. S2CID 3087450.
  7. ^ a b c d "ICD-11 for Mortality and Morbidity Statistics".
  8. ^ "How to get NHS help for your pain". nhs.uk. Jan 18, 2022.
  9. ^ a b "Chronic pain".
  10. ^ "Acute Pain Causes, Symptoms, and Treatments | UPMC". UPMC | Life Changing Medicine. Archived from the original on 2024-01-24. Retrieved 2024-01-24.
  11. ^ a b "Does Chronic Pain Ever Go Away?". Cleveland Clinic.
  12. ^ "What is pain? | British Pain Society". www.britishpainsociety.org.
  13. ^ "ICD-11 for Mortality and Morbidity Statistics". icd.who.int. Archived from the original on 1 August 2018. Retrieved 2022-04-09.
  14. ^ Katz, Joel; Rosenbloom, Brittany N.; Fashler, Samantha (April 2015). "Chronic Pain, Psychopathology, and DSM-5 Somatic Symptom Disorder". Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie. 60 (4): 160–167. doi:10.1177/070674371506000402. ISSN 0706-7437. PMC 4459242. PMID 26174215.
  15. ^ "Chronic Pain".
  16. ^ "Terminology | International Association for the Study of Pain".
  17. ^ "Pain | National Institute of Neurological Disorders and Stroke". www.ninds.nih.gov. Archived from the original on 2025-03-04. Retrieved 2025-03-12.
  18. ^ a b Treede, Rolf-Detlef; Rief, Winfried; Barke, Antonia; Aziz, Qasim; Bennett, Michael I.; Benoliel, Rafael; Cohen, Milton; Evers, Stefan; Finnerup, Nanna B. (June 2015). "A classification of chronic pain for ICD-11". Pain. 156 (6): 1003–1007. doi:10.1097/j.pain.0000000000000160. ISSN 1872-6623. PMC 4450869. PMID 25844555.
  19. ^ Coda BA, Bonica JJ (2001). "General considerations of acute pain". In Loeser D, Bonica JJ (eds.). Bonica's management of pain (3 ed.). Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0-443-05683-3.
  20. ^ Finnerup, N. B.; Kuner, R.; Jensen, T. S. (2021). "Neuropathic Pain: From Mechanisms to Treatment". Physiological Reviews. 101 (1): 259–301. doi:10.1152/physrev.00045.2019. PMID 32584191.
  21. ^ Bogduk N, Merskey H (1994). Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms (second ed.). Seattle: IASP Press. p. 212. ISBN 978-0931092053.
  22. ^ Diagnostic Methods for Neuropathic Pain: A Review of Diagnostic Accuracy Rapid Response Report: Summary with Critical Appraisal. Canadian Agency for Drugs and Technologies in Health. April 2015. PMID 26180859.
  23. ^ Paice JA (Jul–Aug 2003). "Mechanisms and management of neuropathic pain in cancer" (PDF). The Journal of Supportive Oncology. 1 (2): 107–120. PMID 15352654. Archived from the original (PDF) on 2010-01-07. Retrieved 2010-05-03.
  24. ^ Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W (May 2021). "Nociplastic pain: towards an understanding of prevalent pain conditions". Lancet. 397 (10289): 2098–2110. doi:10.1016/S0140-6736(21)00392-5. PMID 34062144. S2CID 235245552.
  25. ^ Rusanescu G, Mao J (October 2014). "Notch3 is necessary for neuronal differentiation and maturation in the adult spinal cord". Journal of Cellular and Molecular Medicine. 18 (10): 2103–16. doi:10.1111/jcmm.12362. PMC 4244024. PMID 25164209.
  26. ^ Apkarian, A. V., Baliki, M. N., Geha, P. Y. (February 2009). "Towards a theory of chronic pain". Progress in Neurobiology. 87 (2): 81–97. doi:10.1016/j.pneurobio.2008.09.018. PMC 2650821. PMID 18952143.
  27. ^ Baloh, R. W. (2019). "Why does pain persist in so many cases?". Sciatica and Chronic Pain. Springer International Publishing. pp. 71–88. doi:10.1007/978-3-319-93904-9_7. ISBN 978-3-319-93903-2. S2CID 56824408.
  28. ^ Hendler, N.H.; Kozikowski, J.G. (November 1993). "Overlooked Physical Diagnoses in Chronic Pain Patients Involved in Litigation". Psychosomatics. 34 (6): 494–501. doi:10.1016/S0033-3182(93)71823-X. PMID 8284339.
  29. ^ a b Neuroscience, Association; Panahi, Reza; Soor, Behnam; Shahbazi, Ali; Haqparest, Abbas (2018). Brain facts. Tehran.Iran: Satish Hasti Publishing House. p. 113. ISBN 978-622-6445-63-4.
  30. ^ Hansson P (1998). Nociceptive and neurogenic pain. Pharmacia & Upjon AB. pp. 52–63.
  31. ^ a b Jena, Monalisa; Mishra, Swati Mishra; Pradhan, Sarita; Jena, Swetalina; Mishra, Sudhansu Sekhar (2015-09-01). "Chronic pain, its management and psychological issues: A review". Asian Journal of Pharmaceutical and Clinical Research: 42–47. ISSN 2455-3891. Archived from the original on 2021-08-02. Retrieved 2024-01-24.
  32. ^ a b Dickenson, Anthony H.; Matthews, Elizabeth A.; Suzuki, Rie (2002). "Neurobiology of neuropathic pain: mode of action of anticonvulsants". European Journal of Pain. 6 (SA): 51–60. doi:10.1053/eujp.2001.0323. ISSN 1532-2149. PMID 11888242. S2CID 31591435. Archived from the original on 2021-10-18. Retrieved 2024-01-24.
  33. ^ a b Jensen MP, Sherlin LH, Hakiman S, Fregni F (2009). "Neuromodulatory approaches for chronic pain management: research findings and clinical implications". Journal of Neurotherapy. 13 (4): 196–213. doi:10.1080/10874200903334371.
  34. ^ Vadivelu N, Sinatra R (October 2005). "Recent advances in elucidating pain mechanisms". Current Opinion in Anesthesiology. 18 (5): 540–7. doi:10.1097/01.aco.0000183109.27297.75. PMID 16534290. S2CID 22012269.
  35. ^ Finan, Patrick H.; Smith, Michael T. (June 2013). "The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism". Sleep Medicine Reviews. 17 (3): 173–183. doi:10.1016/j.smrv.2012.03.003. ISSN 1532-2955. PMC 3519938. PMID 22748562.
  36. ^ a b Ji, Ru-Rong; Berta, Temugin; Nedergaard, Maiken (December 2013). "Glia and pain: is chronic pain a gliopathy?". Pain. 154 (Suppl 1): S10 – S28. doi:10.1016/j.pain.2013.06.022. ISSN 1872-6623. PMC 3858488. PMID 23792284.
  37. ^ Chou R, Huffman LH (October 2007). "Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline". Annals of Internal Medicine. 147 (7): 505–514. doi:10.7326/0003-4819-147-7-200710020-00008. PMID 17909211. S2CID 32719708.
  38. ^ a b c Andrews P, Steultjens M, Riskowski J (January 2018). "Chronic widespread pain prevalence in the general population: A systematic review". European Journal of Pain. 22 (1): 5–18. doi:10.1002/ejp.1090. PMID 28815801.
  39. ^ Cavalcante, Alexandre N.; Sprung, Juraj; Schroeder, Darrell R.; Weingarten, Toby N. (July 2017). "Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression". Anesthesia and Analgesia. 125 (1): 141–146. doi:10.1213/ANE.0000000000001719. ISSN 1526-7598. PMID 27984223. S2CID 11637917.
  40. ^ Gomes, Tara; Greaves, Simon; van den Brink, Wim; Antoniou, Tony; Mamdani, Muhammad M.; Paterson, J. Michael; Martins, Diana; Juurlink, David N. (2018-11-20). "Pregabalin and the Risk for Opioid-Related Death: A Nested Case-Control Study". Annals of Internal Medicine. 169 (10): 732–734. doi:10.7326/M18-1136. ISSN 1539-3704. PMID 30140853.
  41. ^ Watkins, Paul B.; Kaplowitz, Neil; Slattery, John T.; Colonese, Connie R.; Colucci, Salvatore V.; Stewart, Paul W.; Harris, Stephen C. (2006-07-05). "Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial". JAMA. 296 (1): 87–93. doi:10.1001/jama.296.1.87. ISSN 1538-3598. PMID 16820551.
  42. ^ Holubek, William J.; Kalman, Susanne; Hoffman, Robert S. (April 2004). "Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study". Hepatology. 43 (4): 880, author reply 882. doi:10.1002/hep.21106. ISSN 0270-9139. PMID 16557558.
  43. ^ Jalan, Rajiv; Williams, Roger; Bernuau, Jacques (2006-12-23). "Paracetamol: are therapeutic doses entirely safe?". Lancet. 368 (9554): 2195–2196. doi:10.1016/S0140-6736(06)69874-7. ISSN 1474-547X. PMID 17189017. S2CID 40299987.
  44. ^ Lee, Marion; Silverman, Sanford M.; Hansen, Hans; Patel, Vikram B.; Manchikanti, Laxmaiah (2011). "A comprehensive review of opioid-induced hyperalgesia". Pain Physician. 14 (2): 145–161. doi:10.36076/ppj.2011/14/145. ISSN 2150-1149. PMID 21412369.
  45. ^ Turk, Dennis C.; Wilson, Hilary D.; Cahana, Alex (2011-06-25). "Treatment of chronic non-cancer pain". Lancet. 377 (9784): 2226–2235. doi:10.1016/S0140-6736(11)60402-9. ISSN 1474-547X. PMID 21704872. S2CID 24727112.
  46. ^ Farrar, John T.; Young, James P.; LaMoreaux, Linda; Werth, John L.; Poole, Michael R. (November 2001). "Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale". Pain. 94 (2): 149–158. doi:10.1016/S0304-3959(01)00349-9. ISSN 0304-3959. PMID 11690728. S2CID 11875257.
  47. ^ Price, D. D. (2000-06-09). "Psychological and neural mechanisms of the affective dimension of pain". Science. 288 (5472): 1769–1772. Bibcode:2000Sci...288.1769P. doi:10.1126/science.288.5472.1769. ISSN 0036-8075. PMID 10846154.
  48. ^ Clark, Lauren; Jones, Katherine; Pennington, Karen (November 2004). "Pain assessment practices with nursing home residents". Western Journal of Nursing Research. 26 (7): 733–750. doi:10.1177/0193945904267734. ISSN 0193-9459. PMID 15466611. S2CID 42887748.
  49. ^ Closs, S. José; Briggs, Michelle (July 2002). "Patients' verbal descriptions of pain and discomfort following orthopaedic surgery". International Journal of Nursing Studies. 39 (5): 563–572. doi:10.1016/s0020-7489(01)00067-0. ISSN 0020-7489. PMID 11996877.
  50. ^ a b c Tang, Nicole K. Y.; Crane, Catherine (May 2006). "Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links". Psychological Medicine. 36 (5): 575–586. doi:10.1017/S0033291705006859. ISSN 0033-2917. PMID 16420727. S2CID 30586505.
  51. ^ a b c Petrosky, Emiko; Harpaz, Rafael; Fowler, Katherine A.; Bohm, Michele K.; Helmick, Charles G.; Yuan, Keming; Betz, Carter J. (2018-10-02). "Chronic Pain Among Suicide Decedents, 2003 to 2014: Findings From the National Violent Death Reporting System". Annals of Internal Medicine. 169 (7): 448–455. doi:10.7326/M18-0830. ISSN 1539-3704. PMC 6913029. PMID 30208405.
  52. ^ Ferini-Strambi L (2011). "Sleep disorders in multiple sclerosis". Sleep Disorders: Sleep disorders in multiple sclerosis. Handbook of Clinical Neurology. Vol. 99. pp. 1139–1146. doi:10.1016/B978-0-444-52007-4.00025-4. ISBN 978-0444520074. PMID 21056246.
  53. ^ Research, Center for Drug Evaluation and (2020-03-17). "Drug Interactions: What You Should Know". FDA.
  54. ^ a b Torrance N, Elliott AM, Lee AJ, Smith BH (April 2010). "Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study". European Journal of Pain. 14 (4): 380–386. doi:10.1016/j.ejpain.2009.07.006. PMID 19726210. S2CID 22222751.
  55. ^ McBeth J, Chiu YH, Silman AJ, Ray D, Morriss R, Dickens C, et al. (2005). "Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents". Arthritis Research & Therapy. 7 (5) R992: R992 – R1000. doi:10.1186/ar1772. PMC 1257426. PMID 16207340.
  56. ^ IsHak WW, Wen RY, Naghdechi L, Vanle B, Dang J, Knosp M, et al. (2018). "Pain and Depression: A Systematic Review". Harvard Review of Psychiatry. 26 (6): 352–363. doi:10.1097/HRP.0000000000000198. PMID 30407234. S2CID 53212649.
  57. ^ Sheng J, Liu S, Wang Y, Cui R, Zhang X (2017-06-19). "The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain". Neural Plasticity. 2017: 9724371. doi:10.1155/2017/9724371. PMC 5494581. PMID 28706741.
  58. ^ "Effective Coping of Chronic Pain Varies With Psychosocial Resource Profiles". APA Journals Article Spotlight. American Psychological Association. 2019-09-20. Archived from the original on 2020-06-09. Retrieved 2021-02-15.
  59. ^ Mocci, Evelina; Ward, Kathryn; Perry, James A.; Starkweather, Angela; Stone, Laura S.; Schabrun, Siobhan M.; Renn, Cynthia; Dorsey, Susan G.; Ament, Seth A. (2023-10-16). "Genome wide association joint analysis reveals 99 risk loci for pain susceptibility and pleiotropic relationships with psychiatric, metabolic, and immunological traits". PLOS Genetics. 19 (10): e1010977. doi:10.1371/journal.pgen.1010977. ISSN 1553-7404. PMC 10602383. PMID 37844115.
  60. ^ Geha PY, Baliki MN, Harden RN, Bauer WR, Parrish TB, Apkarian AV (November 2008). "The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions". Neuron. 60 (4): 570–81. doi:10.1016/j.neuron.2008.08.022. PMC 2637446. PMID 19038215.
  61. ^ Baliki MN, Geha PY, Apkarian AV, Chialvo DR (February 2008). "Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics". The Journal of Neuroscience. 28 (6): 1398–403. doi:10.1523/JNEUROSCI.4123-07.2008. PMC 6671589. PMID 18256259.
  62. ^ Tagliazucchi E, Balenzuela P, Fraiman D, Chialvo DR (November 2010). "Brain resting state is disrupted in chronic back pain patients". Neuroscience Letters. 485 (1): 26–31. doi:10.1016/j.neulet.2010.08.053. PMC 2954131. PMID 20800649.
  63. ^ May A (July 2008). "Chronic pain may change the structure of the brain". Pain. 137 (1): 7–15. doi:10.1016/j.pain.2008.02.034. PMID 18410991. S2CID 45515001.
  64. ^ Seminowicz DA, Wideman TH, Naso L, Hatami-Khoroushahi Z, Fallatah S, Ware MA, et al. (May 2011). "Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function". The Journal of Neuroscience. 31 (20): 7540–50. doi:10.1523/JNEUROSCI.5280-10.2011. PMC 6622603. PMID 21593339.
  65. ^ a b c d Hochwarter W, Byrne ZS (2010). "The Interactive Effects of Chronic Pain, Guilt, and Perfectionism on Work Outcomes". Journal of Applied Social Psychology. 40 (1): 76–100. doi:10.1111/j.1559-1816.2009.00564.x.
  66. ^ Petrosky, E.; Harpaz, R.; Fowler (2018). "Chronic Pain Among Suicide Decedents, 2003 to 2014: Findings From the National Violent Death Reporting System - PMC". Annals of Internal Medicine. 169 (7): 448–455. doi:10.7326/M18-0830. PMC 6913029. PMID 30208405.
  67. ^ Hardy PA (1997). Chronic pain management: the essentials. UK: Greenwich Medical Media. p. 10. ISBN 978-1900151856. the reduction of suffering and enhanced quality of life .
  68. ^ Main CJ, Spanswick CC (2000). Pain management: an interdisciplinary approach. Churchill Livingstone. ISBN 978-0443056833.
  69. ^ Thienhaus O, Cole BE (2002). "The classification of pain". In Weiner RS (ed.). Pain management: A practical guide for clinicians. CRC Press. p. 29. ISBN 978-0849309267.
  70. ^ Henningsen P, Zipfel S, Herzog W (March 2007). "Management of functional somatic syndromes". Lancet. 369 (9565): 946–55. doi:10.1016/S0140-6736(07)60159-7. PMID 17368156. S2CID 24730085.
  71. ^ Stanos S, Houle TT (May 2006). "Multidisciplinary and interdisciplinary management of chronic pain". Physical Medicine and Rehabilitation Clinics of North America. 17 (2): 435–450, vii. doi:10.1016/j.pmr.2005.12.004. PMID 16616276.
  72. ^ Kang, Youngjoo; Trewern, Louise; Jackman, John; Soni), Anushka Irani (nee; McCartney, David (January 2, 2024). "Chronic pain: supported self-management". BMJ. 384: e072362. doi:10.1136/bmj-2022-072362. PMID 38167273 – via www.bmj.com.
  73. ^ a b Tauben D (May 2015). "Nonopioid medications for pain". Physical Medicine and Rehabilitation Clinics of North America. 26 (2): 219–248. doi:10.1016/j.pmr.2015.01.005. PMID 25952062.
  74. ^ a b Welsch P, Sommer C, Schiltenwolf M, Häuser W (February 2015). "[Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration]". Schmerz (in German). 29 (1): 85–95. doi:10.1007/s00482-014-1436-0. PMID 25376546.
  75. ^ a b c Reuben DB, Alvanzo AA, Ashikaga T, Bogat GA, Callahan CM, Ruffing V, Steffens DC (February 2015). "National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain". Annals of Internal Medicine. 162 (4): 295–300. doi:10.7326/M14-2775. PMID 25581341.
  76. ^ Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. (February 2015). "The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop". Annals of Internal Medicine. 162 (4): 276–286. doi:10.7326/M14-2559. PMID 25581257. S2CID 207538295.
  77. ^ a b c d Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, et al. (May 2017). "Guideline for opioid therapy and chronic noncancer pain". CMAJ. 189 (18): E659 – E666. doi:10.1503/cmaj.170363. PMC 5422149. PMID 28483845.
  78. ^ Rahman, Sadiq; Kidwai, Ali; Rakhamimova, Emiliya; Elias, Murad; Caldwell, William; Bergese, Sergio D. (December 18, 2023). "Clinical Diagnosis and Treatment of Chronic Pain". Diagnostics (Basel, Switzerland). 13 (24): 3689. doi:10.3390/diagnostics13243689. PMC 10743062. PMID 38132273.
  79. ^ "Acetaminophen Monograph for Professionals". Drugs.com. Archived from the original on 2016-06-05. Retrieved 2020-06-30.
  80. ^ Conaghan PG (June 2012). "A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity". Rheumatology International. 32 (6): 1491–502. doi:10.1007/s00296-011-2263-6. PMC 3364420. PMID 22193214.
  81. ^ Vardy J, Agar M (June 2014). "Nonopioid drugs in the treatment of cancer pain". Journal of Clinical Oncology. 32 (16): 1677–1690. doi:10.1200/JCO.2013.52.8356. hdl:10453/115544. PMID 24799483.
  82. ^ Elomrani F, Berrada N, L'annaz S, Ouziane I, Mrabti H, Errihani H (May 2015). "Pain and Cancer: A systematic review". The Gulf Journal of Oncology. 1 (18): 32–37. PMID 26003103.
  83. ^ a b Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ (July 2015). "Amitriptyline for neuropathic pain in adults". The Cochrane Database of Systematic Reviews. 7 (7): CD008242. doi:10.1002/14651858.CD008242.pub3. PMC 6447238. PMID 26146793.
  84. ^ a b Gilron I, Baron R, Jensen T (April 2015). "Neuropathic pain: principles of diagnosis and treatment". Mayo Clinic Proceedings. 90 (4): 532–545. doi:10.1016/j.mayocp.2015.01.018. PMID 25841257.
  85. ^ Jimenez XF, Sundararajan T, Covington EC (June 2018). "A Systematic Review of Atypical Antipsychotics in Chronic Pain Management: Olanzapine Demonstrates Potential in Central Sensitization, Fibromyalgia, and Headache/Migraine". The Clinical Journal of Pain. 34 (6): 585–591. doi:10.1097/AJP.0000000000000567. PMID 29077621. S2CID 699847.
  86. ^ Carey ET, Till SR, As-Sanie S (March 2017). "Pharmacological Management of Chronic Pelvic Pain in Women". Drugs. 77 (3): 285–301. doi:10.1007/s40265-016-0687-8. PMID 28074359. S2CID 35809874.
  87. ^ "Use of nefopam for chronic pain". SPS - Specialist Pharmacy Service. January 5, 2024.
  88. ^ Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, et al. (August 2017). "Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review". Annals of Internal Medicine. 167 (3): 181–191. doi:10.7326/m17-0598. PMID 28715848.
  89. ^ Franklin GM (September 2014). "Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology". Neurology. 83 (14): 1277–1284. doi:10.1212/wnl.0000000000000839. PMID 25267983.
  90. ^ Higgins C, Smith BH, Matthews K (June 2018). "Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis". British Journal of Anaesthesia. 120 (6): 1335–1344. doi:10.1016/j.bja.2018.03.009. PMID 29793599.
  91. ^ Sveinsdottir V, Eriksen HR, Reme SE (2012). "Assessing the role of cognitive behavioral therapy in the management of chronic nonspecific back pain". Journal of Pain Research. 5: 371–380. doi:10.2147/JPR.S25330. PMC 3474159. PMID 23091394.
  92. ^ Castro MM, Daltro C, Kraychete DC, Lopes J (November 2012). "The cognitive behavioral therapy causes an improvement in quality of life in patients with chronic musculoskeletal pain". Arquivos de Neuro-Psiquiatria. 70 (11): 864–868. doi:10.1590/s0004-282x2012001100008. PMID 23175199.
  93. ^ Wicksell RK, Kemani M, Jensen K, Kosek E, Kadetoff D, Sorjonen K, et al. (April 2013). "Acceptance and commitment therapy for fibromyalgia: a randomized controlled trial". European Journal of Pain. 17 (4): 599–611. doi:10.1002/j.1532-2149.2012.00224.x. hdl:10616/44579. PMID 23090719. S2CID 32151525.
  94. ^ Veehof MM, Trompetter HR, Bohlmeijer ET, Schreurs KM (2016). "Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review". Cognitive Behaviour Therapy. 45 (1): 5–31. doi:10.1080/16506073.2015.1098724. PMID 26818413. Archived from the original on 2021-08-28. Retrieved 2025-03-17.
  95. ^ McClintock AS, McCarrick SM, Garland EL, Zeidan F, Zgierska AE (March 2019). "Brief Mindfulness-Based Interventions for Acute and Chronic Pain: A Systematic Review". Journal of Alternative and Complementary Medicine. 25 (3): 265–278. doi:10.1089/acm.2018.0351. PMC 6437625. PMID 30523705.
  96. ^ Long J, Briggs M, Long A, Astin F (October 2016). "Starting where I am: a grounded theory exploration of mindfulness as a facilitator of transition in living with a long-term condition" (PDF). Journal of Advanced Nursing. 72 (10): 2445–2456. doi:10.1111/jan.12998. PMID 27174075. S2CID 4917280. Archived (PDF) from the original on 2020-12-01. Retrieved 2020-09-06.
  97. ^ Brown CA, Jones AK (March 2013). "Psychobiological correlates of improved mental health in patients with musculoskeletal pain after a mindfulness-based pain management program". The Clinical Journal of Pain. 29 (3): 233–244. doi:10.1097/AJP.0b013e31824c5d9f. PMID 22874090. S2CID 33688569.
  98. ^ Niknejad B, Bolier R, Henderson CR, Delgado D, Kozlov E, Löckenhoff CE, Reid MC (June 2018). "Association Between Psychological Interventions and Chronic Pain Outcomes in Older Adults: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 178 (6): 830–839. doi:10.1001/jamainternmed.2018.0756. PMC 6145761. PMID 29801109.
  99. ^ Fisher E, Law E, Dudeney J, Palermo TM, Stewart G, Eccleston C, et al. (Cochrane Pain, Palliative and Supportive Care Group) (September 2018). "Psychological therapies for the management of chronic and recurrent pain in children and adolescents". The Cochrane Database of Systematic Reviews. 9 (9): CD003968. doi:10.1002/14651858.CD003968.pub5. PMC 6257251. PMID 30270423.
  100. ^ a b Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH (April 2017). "Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews". The Cochrane Database of Systematic Reviews. 4 (2): CD011279. doi:10.1002/14651858.CD011279.pub3. PMC 5461882. PMID 28436583.
  101. ^ Ebadi S, Henschke N, Forogh B, Nakhostin Ansari N, van Tulder MW, Babaei-Ghazani A, Fallah E (July 2020). "Therapeutic ultrasound for chronic low back pain". The Cochrane Database of Systematic Reviews. 2020 (7): CD009169. doi:10.1002/14651858.CD009169.pub3. PMC 7390505. PMID 32623724.
  102. ^ a b c d Lee FH, Raja SN (January 2011). "Complementary and alternative medicine in chronic pain". Pain. 152 (1): 28–30. doi:10.1016/j.pain.2010.09.023. PMID 20933330. S2CID 6632695.
  103. ^ Gupta A (2019-10-15). "What are the benefits and harms of acetyl-L-carnitine for treatment of diabetic peripheral neuropathy (DPN)?". Cochrane Clinical Answers. doi:10.1002/cca.2721. ISSN 2050-4217. S2CID 208452418.
  104. ^ Ziegler D (November 2009). "Painful diabetic neuropathy: advantage of novel drugs over old drugs?". Diabetes Care. 32 (suppl_2): S414–419. doi:10.2337/dc09-s350. PMC 2811478. PMID 19875591.
  105. ^ a b Argyriou AA, Chroni E, Koutras A, Iconomou G, Papapetropoulos S, Polychronopoulos P, Kalofonos HP (September 2006). "Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation". Journal of Pain and Symptom Management. 32 (3): 237–244. doi:10.1016/j.jpainsymman.2006.03.013. PMID 16939848.
  106. ^ Elkins G, Johnson A, Fisher W (April 2012). "Cognitive hypnotherapy for pain management". The American Journal of Clinical Hypnosis. 54 (4): 294–310. doi:10.1080/00029157.2011.654284. PMID 22655332. S2CID 40604946.
  107. ^ Thompson T, Terhune DB, Oram C, Sharangparni J, Rouf R, Solmi M, et al. (April 2019). "The effectiveness of hypnosis for pain relief: A systematic review and meta-analysis of 85 controlled experimental trials" (PDF). Neuroscience and Biobehavioral Reviews. 99: 298–310. doi:10.1016/j.neubiorev.2019.02.013. PMID 30790634. S2CID 72334198. Archived (PDF) from the original on 2021-04-13. Retrieved 2020-09-06.
  108. ^ Boldt I, Eriks-Hoogland I, Brinkhof MW, de Bie R, Joggi D, von Elm E (November 2014). "Non-pharmacological interventions for chronic pain in people with spinal cord injury". The Cochrane Database of Systematic Reviews. 2014 (11): CD009177. doi:10.1002/14651858.CD009177.pub2. PMC 11329868. PMID 25432061.
  109. ^ Nugent SM, Morasco BJ, O'Neil ME, Freeman M, Low A, Kondo K, et al. (September 2017). "The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review". Annals of Internal Medicine. 167 (5): 319–331. doi:10.7326/M17-0155. PMID 28806817.
  110. ^ Ciccone CD (February 2017). "Medical Marijuana: Just the Beginning of a Long, Strange Trip?". Physical Therapy. 97 (2): 239–248. doi:10.2522/ptj.20160367. PMID 27660328.
  111. ^ "[115] Cannabinoids for Chronic Pain | Therapeutics Initiative". Therapeutics Initiative. 23 November 2018. Archived from the original on 16 April 2021. Retrieved 17 March 2025.
  112. ^ a b Häuser W, Petzke F, Fitzcharles MA (March 2018). "Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management – An overview of systematic reviews". European Journal of Pain. 22 (3): 455–470. doi:10.1002/ejp.1118. PMID 29034533. S2CID 3443248.
  113. ^ Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, et al. (October 2018). "Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies". Pain. 159 (10): 1932–1954. doi:10.1097/j.pain.0000000000001293. hdl:1959.4/unsworks_51404. PMID 29847469. S2CID 44165877.
  114. ^ Chen YW, Hunt MA, Campbell KL, Peill K, Reid WD (April 2016). "The effect of Tai Chi on four chronic conditions-cancer, osteoarthritis, heart failure and chronic obstructive pulmonary disease: a systematic review and meta-analyses". British Journal of Sports Medicine. 50 (7): 397–407. doi:10.1136/bjsports-2014-094388. PMID 26383108. Archived from the original on 2021-08-28. Retrieved 2019-07-07.
  115. ^ Kong LJ, Lauche R, Klose P, Bu JH, Yang XC, Guo CQ, et al. (April 2016). "Tai Chi for Chronic Pain Conditions: A Systematic Review and Meta-analysis of Randomized Controlled Trials". Scientific Reports. 6 25325. Bibcode:2016NatSR...625325K. doi:10.1038/srep25325. PMC 4850460. PMID 27125299.
  116. ^ Vickers AJ, Vertosick EA, Lewith G, MacPherson H, Foster NE, Sherman KJ, et al. (May 2018). "Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis". The Journal of Pain. 19 (5): 455–474. doi:10.1016/j.jpain.2017.11.005. PMC 5927830. PMID 29198932.
  117. ^ Liu BP, Wang YT, Chen SD (December 2016). "Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis". International Urology and Nephrology. 48 (12): 1977–1991. doi:10.1007/s11255-016-1403-z. PMID 27590134. S2CID 12344832.
  118. ^ O'Connell NE, Marston L, Spencer S, DeSouza LH, Wand BM (April 2018). "Non-invasive brain stimulation techniques for chronic pain". The Cochrane Database of Systematic Reviews. 4 (8): CD008208. doi:10.1002/14651858.CD008208.pub5. PMC 6494527. PMID 29652088.
  119. ^ Bai R, Li C, Xiao Y, Sharma M, Zhang F, Zhao Y (September 2019). "Effectiveness of spa therapy for patients with chronic low back pain: An updated systematic review and meta-analysis". Medicine. 98 (37): e17092. doi:10.1097/MD.0000000000017092. PMC 6750337. PMID 31517832.
  120. ^ Boyd A, Bleakley C, Hurley DA, Gill C, Hannon-Fletcher M, Bell P, McDonough S (April 2019). "Herbal medicinal products or preparations for neuropathic pain". The Cochrane Database of Systematic Reviews. 4 (5): CD010528. doi:10.1002/14651858.CD010528.pub4. PMC 6445324. PMID 30938843.
  121. ^ Luz Júnior MA, Almeida MO, Santos RS, Civile VT, Costa LO (January 2019). "Effectiveness of Kinesio Taping in Patients With Chronic Nonspecific Low Back Pain: A Systematic Review With Meta-analysis". Spine. 44 (1): 68–78. doi:10.1097/BRS.0000000000002756. PMID 29952880. S2CID 49486200.
  122. ^ Laimi K, Mäkilä A, Bärlund E, Katajapuu N, Oksanen A, Seikkula V, et al. (April 2018). "Effectiveness of myofascial release in treatment of chronic musculoskeletal pain: a systematic review". Clinical Rehabilitation. 32 (4): 440–450. doi:10.1177/0269215517732820. PMID 28956477. S2CID 206486404.
  123. ^ Harstall C, Ospina M (June 2003). "How Prevalent Is Chronic Pain?" (PDF). Pain Clinical Updates. XI (2). International Association for the Study of Pain: 1–4. Archived from the original (PDF) on 2017-06-23.
  124. ^ Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (May 2006). "Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment". European Journal of Pain. 10 (4): 287–333. doi:10.1016/j.ejpain.2005.06.009. PMID 16095934. S2CID 22834242. Archived from the original on 2021-04-16. Retrieved 2021-02-23.
  125. ^ "Chronic Pain Syndrome: Practice Essentials, Etiology, Patient Education". eMedicine. February 18, 2022. Archived from the original on March 16, 2024. Retrieved March 5, 2022.
  126. ^ Debono DJ, Hoeksema LJ, Hobbs RD (August 2013). "Caring for patients with chronic pain: pearls and pitfalls". The Journal of the American Osteopathic Association. 113 (8): 620–627. doi:10.7556/jaoa.2013.023. PMID 23918913.
  127. ^ Institute of Medicine of the National Academies Report (2011). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington DC: The National Academies Press.
  128. ^ A Call to Revolutionize Chronic Pain Care in America: An Opportunity in Health Care Reform. The Mayday Fund. 2009.
  129. ^ Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH (November 2010). "The prevalence of chronic pain in United States adults: results of an Internet-based survey". The Journal of Pain. 11 (11): 1230–1239. doi:10.1016/j.jpain.2010.07.002. PMID 20797916. S2CID 27177431.
  130. ^ Rikard, S. Michaela (March 12, 2023). "Chronic Pain Among Adults — United States, 2019–2021". MMWR. Morbidity and Mortality Weekly Report. 72 (15): 379–385. doi:10.15585/mmwr.mm7215a1. PMC 10121254. PMID 37053114. Archived from the original on February 28, 2025. Retrieved March 12, 2025 – via www.cdc.gov.
  131. ^ a b Health Canada (2019-08-08). "Canadian Pain Task Force Report: June 2019". aem. Archived from the original on 2020-07-02. Retrieved 2020-06-30.
  132. ^ a b Mills, Sarah E. E.; Nicolson, Karen P.; Smith, Blair H. (Aug 6, 2019). "Chronic pain: a review of its epidemiology and associated factors in population-based studies". British Journal of Anaesthesia. 123 (2): e273 – e283. doi:10.1016/j.bja.2019.03.023. PMC 6676152. PMID 31079836.
  133. ^ Leo R (2007). Clinical manual of pain management in psychiatry. Washington, DC: American Psychiatric Publishing. p. 58. ISBN 978-1585622757.
  134. ^ Fishbain DA, Cole B, Cutler RB, Lewis J, Rosomoff HL, Rosomoff RS (1 November 2006). "Chronic pain and the measurement of personality: do states influence traits?". Pain Medicine. 7 (6): 509–529. doi:10.1111/j.1526-4637.2006.00239.x. PMID 17112364.
  135. ^ Jess P, Jess T, Beck H, Bech P (May 1998). "Neuroticism in relation to recovery and persisting pain after laparoscopic cholecystectomy". Scandinavian Journal of Gastroenterology. 33 (5): 550–553. doi:10.1080/00365529850172151. PMID 9648998.
  136. ^ Jess P, Bech P (1994). "The validity of Eysenck's neuroticism dimension within the Minnesota Multiphasic Personality Inventory in patients with duodenal ulcer. The Hvidovre Ulcer Project Group". Psychotherapy and Psychosomatics. 62 (3–4): 168–175. doi:10.1159/000288919. PMID 7846260. Archived from the original on 2021-04-28. Retrieved 2011-09-26.
  137. ^ a b Melzack R, Wall PD (1996). The Challenge of Pain (2nd ed.). London: Penguin. pp. 31–32. ISBN 0140256709.
  138. ^ Van Damme S, Crombez G, Bijttebier P, Goubert L, Van Houdenhove B (April 2002). "A confirmatory factor analysis of the Pain Catastrophizing Scale: invariant factor structure across clinical and non-clinical populations". Pain. 96 (3): 319–324. doi:10.1016/S0304-3959(01)00463-8. PMID 11973004. S2CID 19059827.
  139. ^ Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA, Clauw DJ (April 2004). "Pain catastrophizing and neural responses to pain among persons with fibromyalgia". Brain. 127 (Pt 4): 835–843. doi:10.1093/brain/awh098. PMID 14960499.
  140. ^ Severeijns R, van den Hout MA, Vlaeyen JW (June 2005). "The causal status of pain catastrophizing: an experimental test with healthy participants". European Journal of Pain. 9 (3): 257–265. doi:10.1016/j.ejpain.2004.07.005. PMID 15862475. S2CID 43047540.
  141. ^ Fishbain DA, Pulikal A, Lewis JE, Gao J (April 2017). "Chronic Pain Types Differ in Their Reported Prevalence of Post–Traumatic Stress Disorder (PTSD) and There Is Consistent Evidence That Chronic Pain Is Associated with PTSD: An Evidence-Based Structured Systematic Review". Pain Medicine. 18 (4): 711–735. doi:10.1093/pm/pnw065. PMID 27188666. S2CID 205291405.
  142. ^ Morasco BJ, Lovejoy TI, Lu M, Turk DC, Lewis L, Dobscha SK (April 2013). "The relationship between PTSD and chronic pain: mediating role of coping strategies and depression". Pain. 154 (4): 609–616. doi:10.1016/j.pain.2013.01.001. PMC 3609886. PMID 23398939.
  143. ^ Siqveland J, Ruud T, Hauff E (January 2017). "Post-traumatic stress disorder moderates the relationship between trauma exposure and chronic pain". European Journal of Psychotraumatology. 8 (1): 1375337. doi:10.1080/20008198.2017.1375337. PMC 5632777. PMID 29038680.
  144. ^ Sheng, Jiyao; Liu, Shui; Wang, Yicun; Cui, Ranji; Zhang, Xuewen (2017). "The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain". Neural Plasticity. 2017: 9724371. doi:10.1155/2017/9724371. ISSN 2090-5904. PMC 5494581. PMID 28706741.
  145. ^ Surah A, Baranidharan G, Dip PG, Morley S (1 April 2014). "Chronic pain and depression". British Journal of Anaesthesia. 14 (2): 85–9. doi:10.1093/bjaceaccp/mkt046.
  146. ^ "Chronic pain: supporting safer prescribing of analgesics" (PDF). British Medical Association. 2017. Archived (PDF) from the original on 2024-01-19. Retrieved 2023-10-24.
  147. ^ Kreitler S, Niv D (2007). "Cognitive impairment in chronic pain". Pain: Clinical Updates. XV (4): 1–4. Archived from the original (pdf) on 2018-10-30. Retrieved 2019-01-06.
  148. ^ Higgins DM, Martin AM, Baker DG, Vasterling JJ, Risbrough V (March 2018). "The Relationship Between Chronic Pain and Neurocognitive Function: A Systematic Review". The Clinical Journal of Pain. 34 (3): 262–275. doi:10.1097/AJP.0000000000000536. PMC 5771985. PMID 28719507.
  149. ^ Molton IR, Terrill AL (2014). "Overview of persistent pain in older adults". The American Psychologist. 69 (2): 197–207. doi:10.1037/a0035794. PMID 24547805.
  150. ^ Zaza C, Baine N (November 2002). "Cancer pain and psychosocial factors: a critical review of the literature". Journal of Pain and Symptom Management. 24 (5): 526–542. doi:10.1016/s0885-3924(02)00497-9. PMID 12547052.
  151. ^ a b Dehon E, Weiss N, Jones J, Faulconer W, Hinton E, Sterling S (August 2017). Choo EK (ed.). "A Systematic Review of the Impact of Physician Implicit Racial Bias on Clinical Decision Making". Academic Emergency Medicine. 24 (8): 895–904. doi:10.1111/acem.13214. PMID 28472533. S2CID 32634889.
  152. ^ a b c Tait RC, Chibnall JT (2014). "Racial/ethnic disparities in the assessment and treatment of pain: psychosocial perspectives". The American Psychologist. 69 (2): 131–141. doi:10.1037/a0035204. PMID 24547799.
  153. ^ "4 Ways Racism in Health Care Is Still a Problem Today". ThoughtCo. Archived from the original on May 13, 2018. Retrieved May 12, 2018.
  154. ^ Sullivan MJ, Yakobov E, Scott W, Tait R (1 November 2014). "Perceived Injustice and Adverse Recovery Outcomes". Psychological Injury and Law. 7 (4): 325–334. doi:10.1007/s12207-014-9209-8. S2CID 143450160.
  155. ^ Sullivan MJ, Adams H, Horan S, Maher D, Boland D, Gross R (September 2008). "The role of perceived injustice in the experience of chronic pain and disability: scale development and validation". Journal of Occupational Rehabilitation. 18 (3): 249–261. doi:10.1007/s10926-008-9140-5. PMID 18536983. S2CID 23897737.
  156. ^ Bissell DA, Ziadni MS, Sturgeon JA (March 2018). "Perceived injustice in chronic pain: an examination through the lens of predictive processing". Pain Management. 8 (2): 129–138. doi:10.2217/pmt-2017-0051. PMC 6123883. PMID 29451429.
  157. ^ a b Dassieu L, Pagé MG, Lacasse A, Laflamme M, Perron V, Janelle-Montcalm A, et al. (June 2021). "Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain & COVID-19 pan-Canadian study". International Journal for Equity in Health. 20 (1) 147. doi:10.1186/s12939-021-01496-1. PMC 8220113. PMID 34162393.
  158. ^ Weir K (June 2020). "Grieving Life and Loss". Monitor on Psychology. 51 (4). Archived from the original on 2024-03-16. Retrieved 2021-08-22.
  159. ^ Jackson JE (2005). "Stigma, Liminality, and Chronic Pain: Mind-Body Borderlands". American Ethnologist. 32 (3): 332–353. doi:10.1525/ae.2005.32.3.332. ISSN 0094-0496. JSTOR 3805289. Archived from the original on 2021-08-21. Retrieved 2021-08-22.

Further reading

[edit]
[edit]

 

Spinal stenosis
Spinal stenosis
Specialty Orthopedics, neurosurgery
Symptoms Pain, numbness, or weakness in the arms or legs[1]
Complications Loss of bladder control, loss of bowel control, sexual dysfunction[1]
Usual onset Gradual[1]
Types Cervical, thoracic, lumbar[2]
Causes Osteoarthritis, rheumatoid arthritis, spinal tumors, trauma, Paget's disease of the bone, scoliosis, spondylolisthesis, achondroplasia[3]
Diagnostic method Based on symptoms and medical imaging[4]
Differential diagnosis Cauda equina syndrome, osteomylitis, peripheral vascular disease, fibromyalgia[5]
Treatment Medications, exercises, bracing, surgery.[6]
Medication NSAIDs, acetaminophen, steroid injections[7]
Frequency Up to 8% of people[4]

Spinal stenosis is an abnormal narrowing of the spinal canal or neural foramen that results in pressure on the spinal cord or nerve roots.[6] Symptoms may include pain, numbness, or weakness in the arms or legs.[1] Symptoms are typically gradual in onset and improve with leaning forward.[1] Severe symptoms may include loss of bladder control, loss of bowel control, or sexual dysfunction.[1]

Causes may include osteoarthritis, rheumatoid arthritis, spinal tumors, trauma, Paget's disease of the bone, scoliosis, spondylolisthesis, and the genetic condition achondroplasia.[3] It can be classified by the part of the spine affected into cervical, thoracic, and lumbar stenosis.[2] Lumbar stenosis is the most common, followed by cervical stenosis.[2] Diagnosis is generally based on symptoms and medical imaging.[4]

Treatment may involve medications, bracing, or surgery.[6] Medications may include NSAIDs, acetaminophen, anticonvulsants (gabapentinoids) or steroid injections.[8][7] Stretching and strengthening exercises may also be useful.[1] Limiting certain activities may be recommended.[6] Surgery is typically only done if other treatments are not effective, with the usual procedure being a decompressive laminectomy.[7]

Spinal stenosis occurs in as many as 8% of people.[4] It occurs most commonly in people over the age of 50.[9] Males and females are affected equally often.[10] The first modern description of the condition is from 1803 by Antoine Portal, and there is evidence of the condition dating back to Ancient Egypt.[11]

Types

[edit]

The most common forms are lumbar spinal stenosis, at the level of the lower back, and cervical spinal stenosis, which are at the level of the neck.[12] Thoracic spinal stenosis, at the level of the mid-back, is much less common.[13]

In lumbar stenosis, the spinal nerve roots in the lower back are compressed which can lead to symptoms of sciatica (tingling, weakness, or numbness that radiates from the low back and into the buttocks and legs).[citation needed]

Cervical spinal stenosis can be far more dangerous by compressing the spinal cord. Cervical canal stenosis may lead to myelopathy, a serious condition causing symptoms including major body weakness and paralysis.[14] Such severe spinal stenosis symptoms are virtually absent in lumbar stenosis, however, as the spinal cord terminates at the top end of the adult lumbar spine, with only nerve roots (cauda equina) continuing further down.[15] Cervical spinal stenosis is a condition involving narrowing of the spinal canal at the level of the neck. It is frequently due to chronic degeneration,[16] but may also be congenital or traumatic. Treatment frequently is surgical.[16]

Signs and symptoms

[edit]
Drawing showing spinal stenosis with spinal cord compression

Common

[edit]
  • Standing discomfort (94%)
  • Discomfort/pain, in shoulder, arm, and hand (78%)
  • Bilateral symptoms (68%)
  • Numbness at or below the level of involvement (63%)
  • Weakness at or below the level of involvement (43%)
  • Pain or weakness in buttock / thigh only (8%)
  • Pain or weakness below the knee (3%)[17]

Neurological disorders

[edit]
  • Cervical (spondylotic) myelopathy,[18] a syndrome caused by compression of the cervical spinal cord which is associated with "numb and clumsy hands", imbalance, loss of bladder and bowel control, and weakness that can progress to paralysis.
  • Pinched nerve,[19] causing numbness.
  • Intermittent neurogenic claudication[17][20][21] characterized by lower limb numbness, weakness, diffuse or radicular leg pain associated with paresthesia (bilaterally),[20] weakness and/or heaviness in buttocks radiating into lower extremities with walking or prolonged standing.[17] Symptoms occur with extension of spine and are relieved with spine flexion. Minimal to zero symptoms when seated or supine.[17]
A human vertebral column
  • Radiculopathy (with or without radicular pain),[20] a neurologic condition in which nerve root dysfunction causes objective signs such as weakness, loss of sensation, and loss of reflex.
  • Cauda equina syndrome:[22] lower extremity pain, weakness, numbness that may involve perineum and buttocks, associated with bladder and bowel dysfunction.
  • Lower back pain[17][21] due to degenerative disc or joint changes.[23]

Causes

[edit]

Congenital

[edit]
  • Spinal canal is too small at birth
  • Structural deformities of the vertebrae may cause narrowing of the spinal canal.

Aging

[edit]

Any of the factors below may cause the spaces in the spine to narrow.

Arthritis

[edit]

Instability of the spine

[edit]

Trauma

[edit]
  • Accidents and injuries may dislocate the spine and the spinal canal or cause burst fractures that yield fragments of bone that go through the canal.[32]
  • Patients with cervical myelopathy caused by narrowing of the spinal canal are at higher risk of acute spinal cord injury if involved in accidents.[33]

Tumors

[edit]
  • Irregular growths of soft tissue will cause inflammation.
  • Growth of tissue into the canal pressing on nerves, the sac of nerves, or the spinal cord.

Diagnosis

[edit]
Moderate to severe spinal stenosis at the levels of L3/4 and L4/5[further explanation needed]

The diagnosis of spinal stenosis involves a complete evaluation of the spine. The process usually begins with a medical history and physical examination. X-ray and MRI scans are typically used to determine the extent and location of the nerve compression.[citation needed]

Medical history

[edit]

The medical history is the most important aspect of the examination as it will tell the physician about subjective symptoms, possible causes of spinal stenosis, and other possible causes of back pain.[34]

Physical examination

[edit]

The physical examination of a patient with spinal stenosis will give the physician information about exactly where nerve compression is occurring. Some important factors that should be investigated are any areas of sensory abnormalities, numbness, irregular reflexes, and any muscular weakness.[34]

MRI

[edit]

MRI has become the most frequently used study to diagnose spinal stenosis. The MRI uses electromagnetic signals to produce images of the spine. MRIs are helpful because they show more structures, including nerves, muscles, and ligaments than seen on X-rays or CT scans. MRIs are helpful in showing exactly what is causing spinal nerve compression.[citation needed]

Myelography

[edit]

In CT myelography, spinal tap is performed in the low back with dye injected into the spinal fluid. X-rays are performed followed by a CT scan of the spine to help see narrowing of the spinal canal. This is a very effective study in cases of lateral recess stenosis. It is also necessary for patients in which MRI is contraindicated, such as those with implanted pacemakers.[citation needed]

Red flags

[edit]
  • Fever
  • Nocturnal pain
  • Gait disturbance
  • Structural deformity
  • Unexplained weight loss
  • Previous carcinoma
  • Severe pain upon lying down
  • Recent trauma with suspicious fracture
  • Presence of severe or progressive neurologic deficit[22]

Treatments

[edit]

Treatment options are either surgical or non-surgical. The overall evidence is inconclusive whether non-surgical or surgical treatment is better for lumbar spinal stenosis.[35]

Non-surgical treatments

[edit]

The effectiveness of non-surgical treatments is unclear as they have not been well studied.[36]

  • Education about the course of the condition and how to relieve symptoms
  • Medicines to relieve pain and inflammation, such as acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Exercise, to maintain or achieve overall good health, aerobic exercise, such as riding a stationary bicycle, which allows for a forward lean, walking, or swimming can relieve symptoms
  • Weight loss, to relieve symptoms and slow the progression of the stenosis
  • Physical therapy to support self-care.[37] Also may give instructions on stretching and strength exercises that may lead to a decrease in pain and other symptoms.
  • Lumbar epidural steroid or anesthetic injections have low quality evidence to support their use.[36][38]

Surgery

[edit]

Lumbar decompressive laminectomy: This involves removing the roof of bone overlying the spinal canal and thickened ligaments in order to decompress the nerves and sacs of nerves. 70–90% of people have good results.[39]

  • Interlaminar implant: This is a non-fusion U-shaped device that is placed between two bones in the lower back that maintains motion in the spine and keeps the spine stable after a lumbar decompressive surgery. The U-shaped device maintains height between the bones in the spine so nerves can exit freely and extend to lower extremities.[40]
  • Surgery for cervical myelopathy is either conducted from the front or from the back, depending on several factors such as where the compression occurs and how the cervical spine is aligned.
    • Anterior cervical discectomy and fusion: A surgical treatment of nerve root or spinal cord compression by decompressing the spinal cord and nerve roots of the cervical spine with a discectomy in order to stabilize the corresponding vertebrae.
    • Posterior approaches seek to generate space around the spinal cord by removing parts of the posterior elements of the spine. Techniques include laminectomy, laminectomy and fusion, and laminoplasty.

Decompression plus fusion appears no better than decompression alone, while spinal spacers appear better than decompression plus fusion but not better than decompression alone.[41][42] No differences were found in the type of decompression.[42]

Epidemiology

[edit]
  • The NAMCS data shows the incidence in the U.S. population to be 3.9% of 29,964,894 visits for mechanical back problems.[43]
  • It occurs more frequently in women.[8]

Prognosis

[edit]

In a study of 146 patients with lumbar spinal stenosis (mean age, 68 years, 42% women) who did not undergo surgery, followed up for 3 years, the study reported that approximately one-third of participants indicated improvement; approximately 50% reported no change in symptoms; and approximately 10% to 20% of patients condition worsened.[41]

Research

[edit]

A RCT is being conducted in Sweden, to compare surgery versus non-surgical treatment for lumbar spinal stenosis.[44]

See also

[edit]

References

[edit]
  1. ^ a b c d e f g "Spinal Stenosis". National Institute of Arthritis and Musculoskeletal and Skin Diseases. 11 April 2017. Retrieved 19 December 2017.
  2. ^ a b c Canale ST, Beaty JH (2012). Campbell's Operative Orthopaedics E-Book. Elsevier Health Sciences. p. 1994. ISBN 978-0323087186.
  3. ^ a b "Spinal Stenosis". National Institute of Arthritis and Musculoskeletal and Skin Diseases. 11 April 2017. Retrieved 19 December 2017.
  4. ^ a b c d Domino FJ (2010). The 5-Minute Clinical Consult 2011. Lippincott Williams & Wilkins. p. 1224. ISBN 9781608312597.
  5. ^ Ferri FF (2017). Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1. Elsevier Health Sciences. p. 1202. ISBN 9780323529570.
  6. ^ a b c d "Spinal Stenosis". National Institute of Arthritis and Musculoskeletal and Skin Diseases. 11 April 2017. Retrieved 19 December 2017.
  7. ^ a b c "Spinal Stenosis". National Institute of Arthritis and Musculoskeletal and Skin Diseases. 11 April 2017. Retrieved 19 December 2017.
  8. ^ a b Kwon, Ji-won; Moon, Seong-Hwan; Park, Si-Young; Park, Sang-Jun; Park, Sub-Ri; Suk, Kyung-Soo; Kim, Hak-Sun; Lee, Byung Ho (2022-10-31). "Lumbar Spinal Stenosis: Review Update 2022". Asian Spine Journal. 16 (5). Asian Spine Journal (ASJ): 789–798. doi:10.31616/asj.2022.0366. ISSN 1976-1902. PMC 9633250. PMID 36266248. S2CID 253043954.
  9. ^ "Spinal Stenosis". National Institute of Arthritis and Musculoskeletal and Skin Diseases. 11 April 2017. Retrieved 19 December 2017.
  10. ^ "Lumbar Spinal Stenosis". OrthoInfo - AAOS. December 2013. Retrieved 19 December 2017.
  11. ^ Boos N, Aebi M (2008). Spinal Disorders: Fundamentals of Diagnosis and Treatment. Springer Science & Business Media. pp. 21–22. ISBN 9783540690917.
  12. ^ "Spinal Stenosis: What is It, Symptoms, Causes, Treatment & Surgery".
  13. ^ Spinal Stenosis at eMedicine
  14. ^ "CSM Symptoms". Myelopathy.org. Retrieved 2015-11-23.
  15. ^ Waxman SG (2000). Correlative Neuroanatomy (24th ed.).
  16. ^ a b Meyer F, Börm W, Thomé C (May 2008). "Degenerative cervical spinal stenosis: current strategies in diagnosis and treatment". Deutsches Ärzteblatt International. 105 (20): 366–372. doi:10.3238/arztebl.2008.0366. PMC 2696878. PMID 19626174.
  17. ^ a b c d e Mazanec DJ, Podichetty VK, Hsia A (November 2002). "Lumbar canal stenosis: start with nonsurgical therapy". Cleveland Clinic Journal of Medicine. 69 (11): 909–917. doi:10.3949/ccjm.69.11.909. PMID 12430977. S2CID 35370095.
  18. ^ "What is CSM?". Myelopathy.org. Retrieved 2015-11-23.
  19. ^ "Cervical Radiculopathy (Pinched Nerve)". AAOS. Retrieved 13 December 2011.
  20. ^ a b c Costantini A, Buchser E, Van Buyten JP (October 2010). "Spinal cord stimulation for the treatment of chronic pain in patients with lumbar spinal stenosis". Neuromodulation. 13 (4): 275–9, discussion 279–80. doi:10.1111/j.1525-1403.2010.00289.x. PMID 21992882. S2CID 19179148.
  21. ^ a b Goren A, Yildiz N, Topuz O, Findikoglu G, Ardic F (July 2010). "Efficacy of exercise and ultrasound in patients with lumbar spinal stenosis: a prospective randomized controlled trial". Clinical Rehabilitation. 24 (7): 623–631. doi:10.1177/0269215510367539. PMID 20530650. S2CID 22912838.
  22. ^ a b Doorly TP, Lambing CL, Malanga GA, Maurer PM, Rashbaum RF (August 2010). "Algorithmic approach to the management of the patient with lumbar spinal stenosis". The Journal of Family Practice. 59 (8 Suppl Algorithmic): S1–8. PMID 20733968.
  23. ^ Mazanec DJ, Podichetty VK, Hsia A (November 2002). "Lumbar canal stenosis: start with nonsurgical therapy". Cleveland Clinic Journal of Medicine. 69 (11): 909–17. doi:10.3949/ccjm.69.11.909. PMID 12430977.
  24. ^ Park JB, Lee JK, Park SJ, Riew KD (December 2005). "Hypertrophy of ligamentum flavum in lumbar spinal stenosis associated with increased proteinase inhibitor concentration". The Journal of Bone and Joint Surgery. American Volume. 87 (12): 2750–2757. doi:10.2106/JBJS.E.00251. PMID 16322626.
  25. ^ "Ligamentum flavum". Physio-Pedia.com.
  26. ^ "Herniated Disk". Mayo Clinic.
  27. ^ "Degenerative Disk Disease". Mayfield Clinic.
  28. ^ Lim A, D'Urso P (October 2009). "Single-level bilateral facet joint hypertrophy causing thoracic spinal canal stenosis". Journal of Clinical Neuroscience. 16 (10): 1363–1365. doi:10.1016/j.jocn.2008.10.023. PMID 19553126. S2CID 5380624.
  29. ^ Ratini M. "Causes of Spinal Compression Fractures". WebMD.
  30. ^ "Osteoarthritis". The Lecturio Medical Concept Library. Retrieved 22 August 2021.
  31. ^ "Rheumatoid Arthritis". The Lecturio Medical Concept Library. Retrieved 22 August 2021.
  32. ^ "Spinal stenosis Causes". Mayo Clinic. 2012-06-28. Retrieved 2015-04-17.
  33. ^ Wu JC, Ko CC, Yen YS, Huang WC, Chen YC, Liu L, et al. (July 2013). "Epidemiology of cervical spondylotic myelopathy and its risk of causing spinal cord injury: a national cohort study". Neurosurgical Focus. 35 (1): E10. doi:10.3171/2013.4.FOCUS13122. PMID 23815246.
  34. ^ a b Eustice C (14 July 2020). Hershman S (ed.). "Spinal Stenosis - How is Spinal Stenosis Diagnosed?". Verywell Health.
  35. ^ Zaina F, Tomkins-Lane C, Carragee E, Negrini S (January 2016). "Surgical versus non-surgical treatment for lumbar spinal stenosis". The Cochrane Database of Systematic Reviews. 1 (1): CD010264. doi:10.1002/14651858.CD010264.pub2. PMC 6669253. PMID 26824399.
  36. ^ a b Ammendolia C, Stuber KJ, Rok E, Rampersaud R, Kennedy CA, Pennick V, et al. (August 2013). "Nonoperative treatment for lumbar spinal stenosis with neurogenic claudication". The Cochrane Database of Systematic Reviews. 8 (8): CD010712. doi:10.1002/14651858.CD010712. PMC 11787928. PMID 23996271. S2CID 205205990.
  37. ^ "Lumbar Spinal Stenosis-Treatment Overview". WebMD. Retrieved 2015-04-17.
  38. ^ Chou R, Hashimoto R, Friedly J, Fu R, Bougatsos C, Dana T, et al. (September 2015). "Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis: A Systematic Review and Meta-analysis". Annals of Internal Medicine. 163 (5): 373–381. doi:10.7326/M15-0934. PMID 26302454. S2CID 25696028.
  39. ^ Deen Jr HG (2008). "Back and Neck Pain". In Sirven JI, Malamut BL (eds.). Clinical Neurology of the Older Adult (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 220. ISBN 9780781769471.
  40. ^ "coflex Interlaminar Technology - P110008". FDA. 2014-01-17. Archived from the original on July 22, 2013. Retrieved 2015-04-17.
  41. ^ a b Katz, Jeffrey N.; Zimmerman, Zoe E.; Mass, Hanna; Makhni, Melvin C. (2022-05-03). "Diagnosis and Management of Lumbar Spinal Stenosis". JAMA. 327 (17). American Medical Association (AMA): 1688–1699. doi:10.1001/jama.2022.5921. ISSN 0098-7484. PMID 35503342. S2CID 248503972.
  42. ^ a b Machado GC, Ferreira PH, Yoo RI, Harris IA, Pinheiro MB, Koes BW, et al. (November 2016). "Surgical options for lumbar spinal stenosis". The Cochrane Database of Systematic Reviews. 2016 (11): CD012421. doi:10.1002/14651858.cd012421. PMC 6464992. PMID 27801521.
  43. ^ "Spinal Stenosis Details". Spinalstenosis.org. Retrieved 2015-04-17.
  44. ^ Pazarlis K, Punga A, Schizas N, Sandén B, Michaëlsson K, Försth P (August 2019). "Study protocol for a randomised controlled trial with clinical, neurophysiological, laboratory and radiological outcome for surgical versus non-surgical treatment for lumbar spinal stenosis: the Uppsala Spinal Stenosis Trial (UppSten)". BMJ Open. 9 (8): e030578. doi:10.1136/bmjopen-2019-030578. PMC 6707759. PMID 31434781.
[edit]

 

About Casey City